Mechanism of BRD4 Inhibitor-Mediated c-MYC Expression and Regulation of AR Expression to Inhibit Prostate Cancer

Yuzhong Wang,Yongqiang Liu,Li Wang,Chunyan Yang,Zhengdong Nie,Junfang Yuan
DOI: https://doi.org/10.1166/jbn.2024.3874
2024-03-17
Journal of Biomedical Nanotechnology
Abstract:Prostate cancer is a major health challenge, probably because of regulatory role of hormones that has not been clearly studied. Our study explored BRD4's role in the development of prostate cancer. BRD4 expression was detected in tumor tissues by RT-PCR method. Transwell detected cell function after different BRD4 expressions, while Target scan detected the relationship between c-MYC and BRD4, including protein expression between the two luciferase activity and Western-blot. Western-blot detected the protein expression after addition of c-MYC, and further verified the effect of c-MYC expression on AR. We proved that, BRD4 was highly expressed in tumor tissues, and inhibiting BRD4 expression significantly inhibited tumor cell invasion and proliferation. BRD4 targets negative feedback to regulate the expression of c-MYC. Further results showed that, addition of BRD4 activated c-MYC signal transduction and inhibited prostate cancer development. Our study reveals that, BRD4 regulates AR to inhibit prostate cancer by regulating c-MYC. BRD4 is involved in AR-mediated regulation of PCa cells. In addition, inhibiting the expression of BRD4 can inhibit pathological progression of prostate cancer cells.
materials science, biomaterials,nanoscience & nanotechnology
What problem does this paper attempt to address?